OpenURL Connection Search

Select item for more details and to access through your institution.

Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry.
Published in:
International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1247, doi. 10.3390/ijms21041247
By:
- Nguyen, Yann;
- Stirnemann, Jérôme;
- Lautredoux, Florent;
- Cador, Bérengère;
- Bengherbia, Monia;
- Yousfi, Karima;
- Hamroun, Dalil;
- Astudillo, Leonardo;
- Billette de Villemeur, Thierry;
- Brassier, Anaïs;
- Camou, Fabrice;
- Dalbies, Florence;
- Dobbelaere, Dries;
- Gaches, Francis;
- Leguy-Seguin, Vanessa;
- Masseau, Agathe;
- Pers, Yves-Marie;
- Pichard, Samia;
- Serratrice, Christine;
- Berger, Marc G.
Publication type:
Article
A Real-World Investigation of MRI Changes in Bone in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: The EIROS Study.
Published in:
Journal of Clinical Medicine, 2024, v. 13, n. 10, p. 2926, doi. 10.3390/jcm13102926
By:
- Bengherbia, Monia;
- Berger, Marc;
- Hivert, Bénédicte;
- Rigaudier, Florian;
- Bracoud, Luc;
- Vaeterlein, Ole;
- Yousfi, Karima;
- Maric, Michele;
- Malcles, Marie;
- Belmatoug, Nadia
Publication type:
Article
Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1.
Published in:
2019
By:
- Berger, Juliette;
- Vigan, Marie;
- Pereira, Bruno;
- Nguyen, Thu Thuy;
- Froissart, Roseline;
- Belmatoug, Nadia;
- Dalbiès, Florence;
- Masseau, Agathe;
- Rose, Christian;
- Serratrice, Christine;
- Pers, Yves-Marie;
- Bertchansky, Ivan;
- Camou, Fabrice;
- Bengherbia, Monia;
- Bourgne, Céline;
- Caillaud, Catherine;
- Pettazzoni, Magali;
- Berrahal, Amina;
- Stirnemann, Jérôme;
- Mentré, France
Publication type:
journal article

Found: 3

Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry.

A Real-World Investigation of MRI Changes in Bone in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: The EIROS Study.

Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1.